title: The influence of R and S configurations of a series of amphetamine derivatives on quantitative structure-activity relationship models.
abstract: Chiral molecules need special attention in drug design. In this sense, the R and S configurations of a series of thirty-four amphetamines were evaluated by quantitative structure-activity relationship (QSAR). This class of compounds has antidepressant, anti-Parkinson and anti-Alzheimer effects against the enzyme monoamine oxidase A (MAO A). A set of thirty-eight descriptors, including electronic, steric and hydrophobic ones, were calculated. Variable selection was performed through the correlation coefficients followed by the ordered predictor selection (OPS) algorithm. Six descriptors (CHELPG atomic charges C3, C4 and C5, electrophilicity, molecular surface area and logP) were selected for both configurations and a satisfactory model was obtained by PLS regression with three latent variables with R(2)=0.73 and Q(2)=0.60, with external predictability Q(2)=0.68, and R(2)=0.76 and Q(2)=0.67 with external predictability Q(2)=0.50, for R and S configurations, respectively. To confirm the robustness of each model, leave-N-out cross validation (LNO) was carried out and the y-randomization test was used to check if these models present chance correlation. Moreover, both automated or a manual molecular docking indicate that the reaction of ligands with the enzyme occurs via pi-pi stacking interaction with Tyr407, inclined face-to-face interaction with Tyr444, while aromatic hydrogen-hydrogen interactions with Tyr197 are preferable for R instead of S configurations.
authors.affiliation: Institute of Chemistry of São Carlos, University of São Paulo, Av. Trabalhador São-carlense, 400, POB 780, 13560-970 São Carlos, SP, Brazil. maira@iqsc.usp.br
authors.forename: Maíra A C
authors.initials: MA
authors.lastname: Fresqui
authors.forename: Márcia M C
authors.initials: MM
authors.lastname: Ferreira
authors.forename: Milan
authors.initials: M
authors.lastname: Trsic
mesh_terms: D000661:Amphetamine / Q000737:chemistry* / Q000494:pharmacology*; D000818:Animals; D000697:Central Nervous System Stimulants / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D008968:Molecular Conformation; D062105:Molecular Docking Simulation; D008995:Monoamine Oxidase / Q000378:metabolism*; D008996:Monoamine Oxidase Inhibitors / Q000737:chemistry* / Q000494:pharmacology*; D021281:Quantitative Structure-Activity Relationship; D051381:Rats; D013237:Stereoisomerism
chemical_list: D000697:Central Nervous System Stimulants; D008996:Monoamine Oxidase Inhibitors; D000661:Amphetamine; D008995:Monoamine Oxidase